Xbrane And Stada’s Ranibizumab Snapped Up In North America
Bausch + Lomb Licenses Biosimilar Lucentis Rival For US And Canada
• By David Wallace
Eye care specialist Bausch + Lomb has struck a deal for Xbrane and Stada’s Ranibizumab • Source: Shutterstock 
